DVL2 and colorectal carcinoma: Our results showed that silencing DVL2 inhibited FOXM1-increased β-catenin/TCF-4 transcriptional activity in CRC cells, while FOXM1 did not significantly promote the activation of β-catenin/TCF-4 when DVL2 was silenced (Figure 6E, 6F).